Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial - Ansatte ved Biomedicinsk Institut

Biomedicinsk Institut

Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt

D Russell-Jones
Vaag, Allan
O Schmitz
B K Sethi
N Lalic
S Antic
M Zdravkovic
G M Ravn
R Simó
Liraglutide Effect and Action in Diabetes 5 (LEAD-5) met+SU Study Group

Udgivelsesdato: 2009-Oct

Originalsprog	Engelsk
Tidsskrift	Diabetologia
Vol/bind	52
Udgave nummer	10
Sider (fra-til)	2046-55
Antal sider	9
ISSN	0012-186X
DOI	https://doi.org/10.1007/s00125-009-1472-y
Status	Udgivet - 2009

ID: 21487699